SCHEMBL7145378

SCHEMBL7145378

CC(C)(C)OC(=O)Nc1cc(OCC2COC(=O)O2)c(C#Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35
P2RY6 Q15077 1/20 0.35
MAPT P10636 5/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 3/20 0.32
MAPK1 P28482 2/20 0.32
POLB P06746 1/20 0.32
RORC P51449 3/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140004 0.87 RORC (0.32) ALDH1A1RORC
SCHEMBL7140133 0.85 MAPK14 (0.33) ADRA2ADRD5DRD3P2RY6MAPT
SCHEMBL7146760 0.81 ALDH1A1 (0.39) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7143481 0.80 RORC (0.35) RORC
SCHEMBL7143195 0.80 FFAR1 (0.39) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7138020 0.80 ALDH1A1 (0.39) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7138026 0.80 MAPT (0.41) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7141733 0.78 L3MBTL1 (0.40) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7143531 0.78 ALDH1A1 (0.41) MAPTNPC1RAB9AALDH1A1KMT2A
SCHEMBL7139782 0.78 MEN1 (0.36) ADRA2ADRD5DRD3P2RY6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed